Clinical Trial Update: Nivolumab and Ipilimumab in Classical Kaposi Sarcoma (CKS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update exploring nivolumab and ipilimumab in Classic Kaposi Sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classic Kaposi Sarcoma

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Alona Zer | Conditions: Classic Kaposi Sarcoma | Phase 2 | Status: UNKNOWN